Synergism of cytotoxic effects of vinorelbine and paclitaxel in vitro

Cancer Investigation

Volumn 18, Issue 8, 2000, Pages 695-701

  Budman, Daniel R ^a   Calabro, Anthony ^a   Wang, Long G ^a   Liu, Xiao M ^a   Stiel, Lily ^a   Adams, Laurel M ^b   Kreis, Willi ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; NAVELBINE; PACLITAXEL; TAXANE DERIVATIVE; VINCA ALKALOID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL VIABILITY; CYTOTOXICITY; DNA BINDING; DRUG ANTAGONISM; DRUG POTENTIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR CELL LINE;

EID: 0033710625     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357900009012201     Document Type: Article

References (46)

1. Hodgkin's disease
2. Isobolographic analysis of interactions: An update on applications and utility
3. The search for synergy: A critical review from a response surface perspective
4. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxic assays
5. XB596, a promising bis-naphthalimide anti-cancer agent
6. (R,R)-2,2'-[1,2-ethanediylbis-[imino(1-methyl-2,1-ethanediyl)]] -bis [5-nitro-1H-ben[de-isoquinoline- 1.3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis- naphthalimide with potent nonselective tumoricidal activity in vitro
7. Preclinical antitumor activity of 6-hydroxymethylacylfulvene, a semisynthetic derivative of the mushroom toxin Illudin S
8. Quantitative analysis of dose effect relationships: The combined effects of multiple, drugs or enzyme inhibitors
9. Generalized equations for the analysis of inhibitions of Michaelis-Menton and higher order kinetic systems with two or more mutually exclusive and non-exclusive inhibitors
10. A feasibility study of the MTT assay for chemosensitivity testing in ovarian malignancy
11. Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium-based colorimetric assay
12. Unique synergism or antagonism of combinations of chemotherapeutic and hormonal agents in human prostate cancer cell lines
13. New vinca alkaloids and related compounds
14. Investigational drugs
15. Bcl 2 is the guardian of microtubule integrity
16. The effect of antimicrotubule agents on signal transduction pathways of apoptosis: A review
17. Raf-1/bcl-2 phosphorylation: A step from microtubule damage to cell death
18. Current status of vinorelbine for breast cancer
19. Synergy of navelbine-taxol combination treatment in two human breast cancer cell lines
20. Vinorelbine tartrate and paclitaxel combinations: Enhanced activity against in vivo P388 murine leukemia cells
21. In vitro synergy of paclitaxel (Taxol) and vinorelbine (Navelbine) against human melanoma lines
22. Activation of MAP kinase during apoptosis mediated by vinorelbine in MCF-7 cells
23. Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer
24. Pilot study of vinorelbine (Navelbine) and paclitaxel (Taxol) in patients with refractory breast cancer and lung cancer
25. Pilot study of vinorelbine (navelbine) and paclitaxel in patients with refractory non-small cell lung cancer
26. Phase I study of vinorelbine (NVB; navelbine) and paclitaxel (PTX) by simultaneous (sim) 3-hr infusion (inf) for untreated metastatic breast cancer (MBC)
27. Taxoids in combination chemotherapy for metastatic breast cancer
28. Paclitaxel and vinorelbine in anthracycline-pretreated breast cancer: A phase II study
29. Phase I trial of sequential vinorelbine-paclitaxel in patients with metastatic breast cancer: Early evidence of tolerability and efficacy
30. Phase I/II study of paclitaxel and vinorelbine in metastatic breast cancer
31. Phase I study of vinorelbine and paclitaxel in small-cell lung cancer
32. Taxol and vinorelbine: A new active combination for disseminated melanoma
33. Vinorelbine and paclitaxel as first-line chemotherapy in metastatic breast cancer
34. In vitro studies of paclitaxel in combination with either etoposide or vinorelbine: Sequence dependent effects causing synergism or antagonism
35. Cell line designation change: Multidrug-resistant cell line in the NCI anticancer screen
36. Evaluation of three established cell lines derived from patients with prostate cancer (DU 145, PC-3, LnCaP) for phenotype and sensitivity to doxorubicin and vinblastine with or without the new cyclosporin D derivative PSC 833
37. In situ detection of Mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain
38. Antiproliferative activity of vinorelbine (navelbine) against six human melanoma cell lines
39. Effects of prolonged versus short-term exposure paclitaxel (Taxol) on human tumor colony-forming units
40. Cytotoxicity of taxol in vitro against human and rat malignant brain tumors
41. Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol
42. Cytotoxicity of paclitaxel and docetaxel in human neuroblastoma cell lines
43. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity
44. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines
45. Paclitaxel and vinorelbine in advanced non-small cell lung cancer: In vitro and clinical studies